Psychiatric Side Effects Caused by Tirzepatide
DOI:
https://doi.org/10.47363/JNRRR/2026(8)245Keywords:
Eating Disorders, Obesity, TirzepatideAbstract
The work reveals the issue of neuropsychiatric (psychological) safety of GLP-1 receptor agonists of tirzapatide used for the treatment of type 2 diabetes mellitus, obesity and eating disorders. The complex advantages of tirzepatide in relation to metabolic and psychological health are highlighted, making it a safe and effective remedy for patients with severe obesity (BMI>30), including night eating syndrome. The profile of psychiatric side effects when taking tirzepatide is described. The emphasis is placed on the fact that a number of patients use these drugs as a form of corrective (cleansing) behavior. In this regard, when prescribing these drugs, comorbid mental disorders in the patient and early maladaptive patterns should be taken into account.